Manning & Napier Group’s Idexx Laboratories IDXX Stock Holding History
Bought
Maintained
Sold
Other funds holding IDXX
Manning & Napier Group's IDXX Position: Q1 2024 in Review
Manning & Napier Group reduced its Idexx Laboratories (IDXX) stake by 79% in Q1 2024, selling an estimated $87.7M and leaving 42,423 shares worth $22.9M. The position accounts for 0.26% of the portfolio, ranked #80.
Manning & Napier Group first reported a position in IDXX in Q1 2020 and has held it in 17 quarters since. The position peaked at $113M in Q4 2023. 1,148 funds tracked by Wall St. Rank hold IDXX as of Q1 2024.
- Manning & Napier Group held 42,423 shares of Idexx Laboratories worth $22.9M as of Q1 2024.
- Manning & Napier Group sold 160,560 Idexx Laboratories shares in Q1 2024, an estimated $87.7M.
- Idexx Laboratories made up 0.26% of Manning & Napier Group's portfolio in Q1 2024, its #80 holding.
- Manning & Napier Group first reported a position in Idexx Laboratories in Q1 2020 and has held it in 17 quarters since.
- Manning & Napier Group's Idexx Laboratories position peaked at $113M in Q4 2023.
- 1,148 funds tracked by Wall St. Rank held Idexx Laboratories as of Q1 2024.
Based on Manning & Napier Group's 13F filing for Q1 2024, filed 15 Apr 2024.